Healthcare Business

Money close-up

What to Look for in Amgen Earnings

Amgen Inc. (NASDAQ: AMGN) is expected to report its second-quarter financial results after the markets close on Wednesday. In the most recent earnings report, this biotech giant beat estimates on both the ...
Read Full Story »
Prescription drugs

Short Sellers Get Selective on Major Pharma

The short interest data have been released for the July 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Test tubes

JPMorgan Bullish on Biotech: 3 Top Picks to Buy Now

We have noted recently that large pharmaceuticals and biotech have been hammered, and now may be offering outstanding total return potential. While the larger pharmaceutical stocks have done better recently, the ...
Read Full Story »
biotech word cloud

Major Biotechs See Increased Short Interest Bets

The short interest data are out for the July 15 settlement date. Companies within the biotech industry are considered a riskier group of stocks, with big potential upside and big ...
Read Full Story »
Female patient on gurney

Why Analysts Are Thinking M&A Is Back on the Table for Gilead

Gilead Sciences Inc. (NASDAQ: GILD) reported its second-quarter financial results after the markets closed on Monday. In the report we saw weakening trends in the hepatitis C vaccine (HCV) segment, ...
Read Full Story »
Medicine pills

Why Eli Lilly Earnings Are So Dynamic

Eli Lilly and Co. (NYSE: LLY) released its second-quarter earnings report before the markets opened on Tuesday. Currently this company is in the middle of a very dynamic product launch, ...
Read Full Story »
Medicine pills

Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016

Ever since the Hillary Clinton high drug price tweet in September of last year, the major pharmaceuticals and biotechs have struggled, and while performance has improved over the past quarter, ...
Read Full Story »
Prescription Drugs, Pills

Why Analysts Were Not Satisfied With Gilead Earnings

Gilead Sciences Inc. (NASDAQ: GILD) reported second-quarter financial results after the markets closed on Monday. Although this is one of the world’s leading biotech companies, an earnings beat in this ...
Read Full Story »
Pills and tablets

What to Expect From Gilead Sciences Earnings

Gilead Sciences Inc. (NASDAQ: GILD) is scheduled to release its second-quarter financial results after the markets close on Monday. Within just the past month, the stock hit a 52-week low ...
Read Full Story »
Dow

UnitedHealth Up 22%, Leads Dow in 2016

UnitedHealth Group Inc. (NYSE: UNH) shares have risen 22.14% so far in 2016, making it the top performing Dow Jones Industrial Average stock in 2016. The Dow is up 6.58% for ...
Read Full Story »
Female patient on gurney

Is This the Turning Point Puma Biotech Investors Have Waited For?

Puma Biotechnology Inc. (NYSE: PBYI) watched its shares make a handy gain on Friday morning after the firm released updated results from its late-stage breast cancer trial. Although 2016 has been ...
Read Full Story »
M&A

Why the Relypsa Merger Is a Great Idea

Relypsa Inc. (NASDAQ: RLYP) made a splash in the markets on Thursday after the company announced an acquisition agreement. Although the biotech and pharma industries have been hit hard in ...
Read Full Story »
Female patient on gurney

Could This Be the Turning Point for Progenics and Valeant?

Shares of Progenics Pharmaceuticals Inc. (NASDAQ: PGNX) and Valeant Pharmaceuticals International Inc. (NYSE: VRX) made handy gains in the market on Wednesday following a key U.S. Food and Drug Administration (FDA) ...
Read Full Story »
Johnson & Johnson logo

Johnson & Johnson Offers Q2 Earnings Beat, Rosy Guidance

Johnson & Johnson (NYSE: JNJ) released its second-quarter earnings report before the markets opened on Tuesday. As one of the largest health care companies on the market, it helps set a ...
Read Full Story »
hospital

UnitedHealth Lifts Low-End of EPS Forecast After Solid Earnings

UnitedHealth Group Inc. (NYSE: UNH) reported second-quarter 2016 results before markets opened Tuesday. The health insurance and benefits management firm posted adjusted diluted earnings per share (EPS) of $1.96 on revenues ...
Read Full Story »